Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity (Details Narrative)

Stockholders’ Equity (Details Narrative) - USD ($) $ / shares in Units, $ in Thousands	1 Months Ended				3 Months Ended		9 Months Ended
	Mar. 31, 2022	Feb. 28, 2022	Jan. 31, 2022	Aug. 31, 2021	Sep. 30, 2022	Mar. 31, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Jun. 30, 2022
Subsidiary, Sale of Stock [Line Items]
Common stock shares, outstanding							15,016,295		15,016,295
Preferred stock, shares issued							950,000		0
Preferred stock, par value (in dollars per share)							$ 0.001		$ 0.001
Share price							$ 10.00
Purchase price							$ 9,500
Proceeds from warrant exercises								$ 4
Stock-based compensation							$ 965	1,038
Common Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Issuance of common stock, net (in shares)						1,151,000
Common Stock [Member] \| Restricted stock agreement with Maxim Group, LLC [Member]
Subsidiary, Sale of Stock [Line Items]
Number of shares agreed to issue				50,000
Vesting period				12 months
Stock-based compensation					$ 27,000			$ 54,000
JT Pharmaceuticals [Member]
Subsidiary, Sale of Stock [Line Items]
Issuance of common stock, net (in shares)			51,021
Milestone payment			$ 100,000
Pre-Funded Warrants [Member]
Subsidiary, Sale of Stock [Line Items]
Number of warrants issued										974,242
Proceeds from warrant exercises	$ 1,000
February 2022 Offerings [Member]
Subsidiary, Sale of Stock [Line Items]
Issuance of common stock, net (in shares)		1,100,000
Proceeds from sale of common stock		$ 5,000
February 2022 Offerings [Member] \| Pre-Funded Warrants [Member]
Subsidiary, Sale of Stock [Line Items]
Number of warrants issued		2,274,242
Exercise price of warrants (in dollars per share)		$ 0.001
February 2022 Offerings [Member] \| Unregistered prefunded warrants [Member]
Subsidiary, Sale of Stock [Line Items]
Number of warrants issued		1,289,796
Exercise price of warrants (in dollars per share)		$ 0.001
February 2022 Offerings [Member] \| Unregistered five year and six month warrants [Member]
Subsidiary, Sale of Stock [Line Items]
Number of warrants issued		4,664,038
Exercise price of warrants (in dollars per share)		$ 1.14
2015 Omnibus Equity Incentive Plan [Member]
Subsidiary, Sale of Stock [Line Items]
Number of shares agreed to issue							2,500,000